Latest Advances

  • Condition: High-risk IgA Nephropathy
  • Journal: Medicine
  • Treatment Used: Immunosuppressive Therapies
  • Number of Patients: 3012
  • Published —
In this study, researchers evaluated the safety and effectiveness of immunosuppressive therapies for the treatment of high-risk IgA nephropathy.
  • Condition: Systemic Lupus Erythematosus
  • Journal: BioMed research international
  • Treatment Used: Mycophenolate Mofetil
  • Number of Patients: 119
  • Published —
In this study, researchers evaluated the safety and effectiveness of mycophenolate mofetil for the treatment of systemic lupus erythematosus in Japanese patients.
  • Condition: Acute Tracheal Necrosis after Intubation with Childhood Onset Systemic Lupus Erythematosus
  • Journal: Chest
  • Treatment Used: High-Dose Steroid Therapy
  • Number of Patients: 1
  • Published —
This case report describes a childhood onset systemic lupus erythematosus patient with acute tracheal necrosis that she developed after intubation.
  • Condition: Focal Segmental Glomerular Sclerosis (FSGS) Recurrence in Patient with Kidney Transplant
  • Journal: The American journal of case reports
  • Treatment Used: Cyclophosphamide
  • Number of Patients: 1
  • Published —
This case report describes a 24-year-old woman kidney transplant recipient diagnosed with primary focal segmental glomerular sclerosis (FSGS) treated with cyclophosphamide.
  • Condition: Ankylosing Spondylitis
  • Journal: BMJ case reports
  • Treatment Used: Infliximab
  • Number of Patients: 1
  • Published —
This case report describes a patient with ankylosing spondylitis.
  • Condition: Membranous Nepropathy
  • Journal: Journal of Nepal Health Research Council
  • Treatment Used: Rituximab
  • Number of Patients: 0
  • Published —
This article discusses the effectiveness of rituximab in the treatment of membranous nephropathy (autoimmune kidney disease).
  • Condition: Lupus Membranous Nephropathy
  • Journal: RMD open
  • Treatment Used: Filgotinib and Lanraplenib
  • Number of Patients: 9
  • Published —
In this study, researchers evaluated the safety and effectiveness of filgotinib and lanraplenib for the treatment of lupus membranous nephropathy.
  • Condition: Systemic Lupus Erythematosus with Chylothorax and/or Chylous Ascites
  • Journal: Medicine
  • Treatment Used: Glucocorticoids, Immunosuppressants, and Surgery
  • Number of Patients: 15
  • Published —
The study researched treatment for systemic lupus erythematosus with chylothorax and/or chylous ascites.
  • Condition: IgA Nephropathy (IgAN) with Partial Crescent Formation
  • Journal: Discovery medicine
  • Treatment Used: Immunosuppresants
  • Number of Patients: NULL
  • Published —
This study evaluated the effectiveness of immunosuppressants (drugs that inhibit or prevent activity of the immune system) in patients with IgA nephropathy (kidney disease that occurs when an antibody called immunoglobulin A builds up in the kidneys; IgAN) with partial crescent formation.
  • Condition: Immunoglobulin A-Nephropathy (IgAN)
  • Journal: Terapevticheskii arkhiv
  • Treatment Used: Immunosuppressive Therapy (IST) and Tonsillectomy (TE)
  • Number of Patients: 367
  • Published —
This study evaluated the effectiveness of immunosuppressive therapy (drugs that inhibit or prevent activity of the immune system; IST) and tonsillectomy (surgical removal of the tonsils; TE) in patients with immunoglobulin A-nephropathy (kidney disease that occurs when IgA deposits build up in the kidneys; IgAN).
  • Condition: Membranous Nephropathy (MN)
  • Journal: Terapevticheskii arkhiv
  • Treatment Used: Cyclophosphane, Calcineurin Inhibitors, Rituximab, and Anti-CD20 Antibody Therapy
  • Number of Patients: 0
  • Published —
This article discusses newer treatments for patients with membranous nephropathy (kidney disease; MN).
  • Condition: Chronic Kidney Disease
  • Journal: The lancet. Diabetes & endocrinology
  • Treatment Used: Dapagliflozin
  • Number of Patients: 4304
  • Published —
This study evaluated the effects of dapagliflozin on major adverse kidney and cardiovascular (heart and vessels) events in patients with diabetic and non-diabetic chronic kidney disease (when the kidneys are damaged and can’t filter blood the way they should).
Showing 1-12 of 181